Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-24-036572

Chief Executive Officer sold 16,519 shares at $9.50 ($156,931)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barrow Robert Chief Executive Officer 2024-03-25 Sale 10b5-1 −16,519 $9.50 $156,931 580,202 D
Open-market sales · 16,519 sh · avg $9.50 · $156,931
Loading xslF345X05/ownership.xml…